Clinical Trial Update: The Deferasirox-calcium-vitamin D3 Therapy for Postmenopausal Osteoporosis (PMOP) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update examining a deferasirox-calcium-vitamin D3 combination for postmenopausal osteoporosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• Deferasirox-calcium-vitamin D3 therapy (deferasirox-calcium-vitamin D3)

Snippet

Sponsor: Second Affiliated Hospital of Soochow University | Conditions: Postmenopausal Osteoporosis | Phase 2 | Status: UNKNOWN